×
About 6,493 results

ALLMedicine Diabetic Ketoacidosis Center

Research & Reviews  2,351 results

Etiologies, Trends and Predictors of 30-Day Pediatric Readmissions after Hospitalizatio...
https://doi.org/10.1111/pedi.13059
Pediatric Diabetes; Bhatt P, Dave M et. al.

May 28th, 2020 - To determine the causes, predictors, and trends of 30-day readmissions following hospitalizations for pediatric diabetic ketoacidosis (DKA) in the United States (US) from 2010-2014. We used International Classification of Diseases, ninth revision,...

Children with onset-ketoacidosis are admitted to the nearest hospital available, regard...
https://doi.org/10.1515/jpem-2020-0038
Journal of Pediatric Endocrinology & Metabolism : JPEM; Nagl K, Rosenbauer J et. al.

May 24th, 2020 - Background To investigate longitudinal trends of admissions with diabetic ketoacidosis (DKA) in new-onset type 1 diabetes (T1D) and subsequent duration of hospitalization in association with structural health care properties, such as size of treat...

Incidence Trends of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabe...
https://doi.org/10.1016/j.jpeds.2020.02.069
The Journal of Pediatrics; Kao KT, Islam N et. al.

May 24th, 2020 - To estimate the 11-year incidence trend of diabetic ketoacidosis (DKA) at and after the diagnosis of type 1 diabetes. A retrospective cohort study using a population-based administrative cohort diagnosed with type 1 diabetes at <20 years of age fr...

Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Me...
https://doi.org/10.1007/s40272-020-00397-0
Paediatric Drugs; Castellanos L, Tuffaha M et. al.

May 24th, 2020 - Diabetic ketoacidosis (DKA) is the end result of insulin deficiency in type 1 diabetes mellitus (T1D). Loss of insulin production leads to profound catabolism with increased gluconeogenesis, glycogenolysis, lipolysis, and muscle proteolysis causin...

Hyperlactatemia in diabetic ketoacidosis is common and can be prolonged: lactate time-s...
https://doi.org/10.1007/s10877-020-00532-9
Journal of Clinical Monitoring and Computing; Morgan TJ, Scott PH et. al.

May 19th, 2020 - Hyperlactatemia is a documented complication of diabetic ketoacidosis (DKA). Lactate responses during DKA treatment have not been studied and were the focus of this investigation. Blood gas and electrolyte data from 25 DKA admissions to ICU were s...

see more →

Guidelines  7 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycem...
https://cdn.ymaws.com/www.ispad.org/resource/resmgr/consensus_guidelines_2018_/11.diabetic_ketoacidosis_and.pdf

Apr 10th, 2018 - The biochemical criteria for the diagnosis of diabetic ketoacidosis (DKA) are: Hyperglycemia (blood glucose >11 mmol/L [≈200 mg/dL]) Venous pH <7. 3 or serum bicarbonate <15 mmol/L Ketonemia (blood ß-hydroxybuyrate ≥3 mmol/L) or moderate or large k.

Management of hyperosmolar hyperglycaemic state in adults with diabetes.
https://doi.org/10.1111/dme.12757
Diabetic Medicine : a Journal of the British Diabetic Association; Scott AR, et. al.

May 19th, 2015 - Hyperglycaemic hyperosmolar state (HHS) is a medical emergency, which differs from diabetic ketoacidosis (DKA) and requires a different approach. The present article summarizes the recent guidance on HHS that has been produced by the Joint British...

ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglyce...
https://doi.org/10.1111/pedi.12165
Pediatric Diabetes; Wolfsdorf JI, Allgrove J et. al.

Jul 21st, 2014 - ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state.|2014|Wolfsdorf JI,Allgrove J,Craig ME,Edge J,Glaser N,|trends,adverse effects,blood,complications,drug therapy,therapy,blood,complicatio...

see more →

Drugs  633 results see all →

Clinicaltrials.gov  3,199 results

Etiologies, Trends and Predictors of 30-Day Pediatric Readmissions after Hospitalizatio...
https://doi.org/10.1111/pedi.13059
Pediatric Diabetes; Bhatt P, Dave M et. al.

May 28th, 2020 - To determine the causes, predictors, and trends of 30-day readmissions following hospitalizations for pediatric diabetic ketoacidosis (DKA) in the United States (US) from 2010-2014. We used International Classification of Diseases, ninth revision,...

Children with onset-ketoacidosis are admitted to the nearest hospital available, regard...
https://doi.org/10.1515/jpem-2020-0038
Journal of Pediatric Endocrinology & Metabolism : JPEM; Nagl K, Rosenbauer J et. al.

May 24th, 2020 - Background To investigate longitudinal trends of admissions with diabetic ketoacidosis (DKA) in new-onset type 1 diabetes (T1D) and subsequent duration of hospitalization in association with structural health care properties, such as size of treat...

Incidence Trends of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabe...
https://doi.org/10.1016/j.jpeds.2020.02.069
The Journal of Pediatrics; Kao KT, Islam N et. al.

May 24th, 2020 - To estimate the 11-year incidence trend of diabetic ketoacidosis (DKA) at and after the diagnosis of type 1 diabetes. A retrospective cohort study using a population-based administrative cohort diagnosed with type 1 diabetes at <20 years of age fr...

Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Me...
https://doi.org/10.1007/s40272-020-00397-0
Paediatric Drugs; Castellanos L, Tuffaha M et. al.

May 24th, 2020 - Diabetic ketoacidosis (DKA) is the end result of insulin deficiency in type 1 diabetes mellitus (T1D). Loss of insulin production leads to profound catabolism with increased gluconeogenesis, glycogenolysis, lipolysis, and muscle proteolysis causin...

Glipizide - glipizide tablet, extended release-Bryant Ranch Prepack
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4301583-cafb-46ac-898e-9da3b45d6543

May 21st, 2020 - Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets is a sulfonylurea indicated as an adjunct to diet and exerc...

see more →

News  299 results

Call for More Transparency in Gray Area of Post-Approval Drug Studies
https://www.medscape.com/viewarticle/930045

May 5th, 2020 - Sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes "have received several serious safety warnings since approval, but the number, timeliness, and strength of these safety communications have differed between Ame...

More Guidance on Inpatient Management of Blood Glucose in COVID-19
https://www.medscape.com/viewarticle/929957

May 4th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. New guidance is available for managing inpatient hyperglycemia and diabetic ketoacidosis (DKA) in COVID-19 patients with diabetes using subcutane...

New Study of Diabetes Drug for COVID-19 Raises Eyebrows
https://www.medscape.com/viewarticle/929716

Apr 29th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A just-launched study of the type 2 diabetes agent dapagliflozin (Farxiga, AstraZeneca) in patients with mild-moderate COVID-19 is raising eyebrow...

Be Vigilant for Signs of Diabetes During COVID-19 Lockdown
https://www.medscape.com/viewarticle/929243

Apr 22nd, 2020 - As concerns about coronavirus deter people from seeking hospital care, endocrinologists and a leading UK charity are calling for general practitioners (GPs) and the public to be aware of the signs and symptoms of type 1 diabetes. Diabetes UK say t...

Checklist to Manage Hyperglycemia, DKA in Severe COVID-19
https://www.medscape.com/viewarticle/929092

Apr 20th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. With evidence mounting that hyperglycemia and diabetic ketoacidosis (DKA) are contributing to morbidity and mortality in COVID-19 — including amon...

see more →

Patient Education  4 results see all →